These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 778303)

  • 61. Characterization of cephalosporin resistance in clinical isolates of Escherichia coli.
    Sawai T; Ando-Kuroda I; Murata T; Yamagishi S
    J Pharmacobiodyn; 1980 Jul; 3(7):364-6. PubMed ID: 7009827
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Reassessment of the "class" concept of disk susceptibility testing. Cephalothin disks versus minimal inhibitory concentrations with eleven cephalosporins.
    Barry AL; Thornsberry C; Jones RN; Fuchs PC; Gavan TL; Gerlach EH
    Am J Clin Pathol; 1978 Dec; 70(6):909-13. PubMed ID: 727174
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparative activity of cefoxitin, ampicillin/sulbactam, and imipenem against clinical isolates of Escherichia coli and Klebsiella pneumoniae.
    Shungu DL; Ponticas S; Gill CJ
    Clin Ther; 1989; 11(3):315-8. PubMed ID: 2663161
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [On the activity of cefoxitin against enterobacteriaceae and staphylococcus aureus in vitro (author's transl)].
    Krasemann C; Mohr G
    Arzneimittelforschung; 1977; 27(11):2029-31. PubMed ID: 579995
    [No Abstract]   [Full Text] [Related]  

  • 65. Sensitivity of gentamicin-resistant Enterobacteriaceae to cefamandole and cefoxitin.
    Rosenthal SL; Freundlich LF; Quraishi MA
    Chemotherapy; 1979; 25(3):157-61. PubMed ID: 456076
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Antimicrobial studies in vitro with cephacetrile, a new cephalosporin derivative.
    Knüsel F; Konopka EA; Gelzer J; Rosselet A
    Arzneimittelforschung; 1974 Sep; 24(9b):1451-5. PubMed ID: 4215433
    [No Abstract]   [Full Text] [Related]  

  • 67. Infections due to endemic, multiply resistant gram-negative rods: sensitivity to and therapy with cefoxitin.
    Alford RH
    Rev Infect Dis; 1979; 1(1):175-82. PubMed ID: 400932
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Susceptibility to antimicrobial agents of 2,060 strains of different bacteria isolated in infectious processes in children].
    Filloy L; Borjas E; Sierra A
    Bol Med Hosp Infant Mex; 1981; 38(1):13-21. PubMed ID: 7025858
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Identification of a novel cephalosporinase (DHA-3) in Klebsiella pneumoniae isolated in Taiwan.
    Wu LT; Hung SW; Chuang YC; Chen HE; Jones RN; Yu WL
    Clin Microbiol Infect; 2005 Nov; 11(11):893-7. PubMed ID: 16216104
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Antistaphylococcal activity and beta-lactamase resistance of newer cephalosporins.
    Farrar WE; Gramling PK
    J Infect Dis; 1976 Jun; 133(6):691-5. PubMed ID: 1047087
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A comparison of the in vitro activity of a new cephalosporin, cefuroxime, and cephalothin against 810 clinical isolates.
    Skar AG; Midtvedt T; Dahl O
    NIPH Ann; 1979 Dec; 2(2):31-40. PubMed ID: 398460
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Differential susceptibility of indole-positive and -negative strains of Klebsiella pneumoniae to cefazolin, choramphenicol and tetracycline.
    Nishida M; Asano H; Kamimura T; Yokota Y
    Chemotherapy; 1978; 24(3):154-60. PubMed ID: 350514
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Comparative clinical pharmacology of intravenous cefoxitin and cephalothin.
    Sonneville PF; Kartodirdjo RR; Skeggs H; Till AE; Martin CM
    Eur J Clin Pharmacol; 1976 Mar; 09(5-6):397-403. PubMed ID: 971703
    [TBL] [Abstract][Full Text] [Related]  

  • 74. 7-(Alpha-(1-methyl-4-pyridinothio)-acetamido) cephalosporanic acid.
    Buck RE; Leitner F; Price KE
    Antimicrob Agents Chemother; 1972 Jan; 1(1):67-72. PubMed ID: 4670430
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Use of cefoxitin sodium in difficult-to-treat infections.
    Ramachandran Nair S; Cherubin CE
    J Antimicrob Chemother; 1978 Jul; 4(B):167-78. PubMed ID: 357383
    [No Abstract]   [Full Text] [Related]  

  • 76. Susceptibility of Staphylococcus aureus to cefaclor and cephalothin: laboratory and clinical studies.
    Gray BM; Hubbell CA; Dillon HC
    Antimicrob Agents Chemother; 1978 Jun; 13(6):988-91. PubMed ID: 677865
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cefoxitin and cephalothin: antimicrobial activity, human pharmacokinetics, and toxicology.
    Brumfitt W; Kosmidis J; Hamilton-Miller JM; Gilchrist JN
    Antimicrob Agents Chemother; 1974 Sep; 6(3):290-9. PubMed ID: 15830475
    [TBL] [Abstract][Full Text] [Related]  

  • 78. An in vivo comparison of cefoxitin, a semi-synthetic cephamycin, with cephalothin.
    Hamilton-Miller JM; Kerry DW; Brumfitt W
    J Antibiot (Tokyo); 1974 Jan; 27(1):42-8. PubMed ID: 4843049
    [No Abstract]   [Full Text] [Related]  

  • 79. Klebsiella pneumoniae: in vitro antibacterial activity of cefoxitin and amikacin, alone and in combination.
    Yoshikawa TT
    J Antimicrob Chemother; 1979 Nov; 5(6):730-1. PubMed ID: 395157
    [No Abstract]   [Full Text] [Related]  

  • 80. Sporadic emergence of Klebsiella pneumoniae strains resistant to cefepime and cefpirome in Greek hospitals.
    Tzouvelekis LS; Tzelepi E; Prinarakis E; Gazouli M; Katrahoura A; Giakkoupi P; Paniara O; Legakis NJ
    J Clin Microbiol; 1998 Jan; 36(1):266-8. PubMed ID: 9431962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.